Role of novel biomarkers in diabetic cardiomyopathy

Diabetic cardiomyopathy (DCM) is commonly defined as cardiomyopathy in patients with diabetes mellitus in the absence of coronary artery disease and hypertension. As DCM is now recognized as a cause of substantial morbidity and mortality among patients with diabetes mellitus and clinical diagnosis i...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumric, Marko, Ticinovic Kurir, Tina, Borovac, Josip A, Bozic, Josko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192249/
https://www.ncbi.nlm.nih.gov/pubmed/34168722
http://dx.doi.org/10.4239/wjd.v12.i6.685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192249/
https://www.ncbi.nlm.nih.gov/pubmed/34168722
http://dx.doi.org/10.4239/wjd.v12.i6.685

Ejemplares similares